Lataa...
Landiolol for managing atrial fibrillation in intensive care
Landiolol is an injectable ultrashort acting beta-blocker with high beta1 selectivity indicated for heart rate control of atrial fibrillation in the emergency and critical care setting. Accordingly, landiolol is associated with a significantly reduced risk of arterial hypotension and negative inotro...
Tallennettuna:
| Julkaisussa: | Eur Heart J Suppl |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5909768/ https://ncbi.nlm.nih.gov/pubmed/30188960 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/sux039 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|